2023
DOI: 10.26442/20751753.2023.1.202079
|View full text |Cite
|
Sign up to set email alerts
|

Endocan is a key player in cardiovascular disease: A review

Abstract: In recent years, the attention of scientists has been actively focused on studying the role of endocan as a biological marker of endothelial dysfunction in cardiovascular diseases. Until recent years, endocan has been studied in acute kidney injury, chronic kidney disease, and renal replacement therapy. Endocan, formerly known as endothelial cell-specific molecule-1, is a soluble dermatan sulfate proteoglycan expressed and secreted into the circulation from endothelial cells. Currently available studies demons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 62 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?